In early 2020, Pfizer Communications and Policy Chief Sally Susman was stunned when the head of the pharmaceutical company revealed plans to bring a COVID-19 vaccine forward by the end of that year.
Nov 5 (Reuters) - Pfizer (PFE.N) plans to sweeten its bid for Metsera (MTSR.O), a person familiar with the matter told ...
(Reuters) -Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a foothold in the fast-growing obesity ...